Tag: disproportionality analysis

A large pharmacovigilance analysis of over 30,000 adverse event reports confirms riociguat's known risks and uncovers new safety signals, including ...

A pharmacovigilance analysis of US and Japanese adverse event databases finds that PD-1 and PD-L1 checkpoint inhibitors show a robust, ...

A pharmacovigilance analysis of nearly 6,000 FDA adverse event reports reveals that the two FDA-approved oral SGLT2 inhibitors for feline ...

A sweeping analysis of more than 21,500 FDA adverse event reports has mapped which anticancer drugs most strongly trigger hand-foot ...